These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31236781)

  • 1. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form.
    Lam M; Ghafourian T; Nokhodchi A
    Drug Deliv Transl Res; 2020 Feb; 10(1):43-58. PubMed ID: 31286452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting performance and manufacturability of naproxen Liqui-Pellet.
    Lam M; Nokhodchi A
    Daru; 2020 Dec; 28(2):567-579. PubMed ID: 32757155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquisolid Pellets and Liqui-Pellets Are Not Different.
    Pezzini BR; Beringhs AO; Ferraz HG; Silva MAS; Stulzer HK; Sonaglio D
    AAPS PharmSciTech; 2020 Jan; 21(2):72. PubMed ID: 31953566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.
    Lam M; Asare-Addo K; Nokhodchi A
    AAPS PharmSciTech; 2021 Mar; 22(3):85. PubMed ID: 33650023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.
    Agiba AM
    Curr Drug Deliv; 2020; 17(9):736-754. PubMed ID: 32729418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquisolid System and Liqui-Mass System Are Not the Same.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2020 Mar; 21(3):105. PubMed ID: 32180042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.
    Khames A
    Drug Deliv; 2017 Nov; 24(1):328-338. PubMed ID: 28165818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2.
    Lam M; Asare-Addo K; Nokhodchi A
    Iran J Basic Med Sci; 2021 Jan; 24(1):108-115. PubMed ID: 33643578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liqui-Mass Technology as a Novel Tool to Produce Sustained Release Liqui-Tablet Made from Liqui-Pellets.
    Lam M; Nashed N; Nokhodchi A
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into liquisolid system processability based on the SeDeM Expert System approach.
    Vasiljević I; Turković E; Nenadović S; Mirković M; Zimmer A; Parojčić J; Aleksić I
    Int J Pharm; 2021 Aug; 605():120847. PubMed ID: 34216763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
    Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
    Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhancing of drug bioavailability using liquisolid system formulation].
    Gajdziok J; Vraníková B
    Ceska Slov Farm; 2015 Jun; 64(3):55-66. PubMed ID: 26400228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.